Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua S Davis

Showing results (1-10 of 210) with videos related to

Pageof 21
Sort By:
Trials|September 21, 2022
Creating concise and readable patient information sheets for interventional studies in Australia: are we there yet?Tanya Symons, Joshua S Davis
Australian and New Zealand Journal of Public Health|July 24, 2010
Acute hospital admission for sepsis: an important but under-utilised opportunity for smoking cessation interventionsMark McMillan, Joshua S Davis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Rhabdomyolysis associated with dengue virus infectionJoshua S Davis, Peter Bourke
Critical Care Medicine|December 15, 2010
Is plasma arginine concentration decreased in patients with sepsis? A systematic review and meta-analysisJoshua S Davis, Nicholas M Anstey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2019
Combination Therapy for MRSA Bacteremia: To ß or Not to ß?Thomas L Holland, Joshua S Davis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2020
Measuring the MeaningfulJohn F McNamara, Joshua S Davis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 16, 2020
Combination Therapy for Staphylococcus aureus Bacteremia: Hopes Dashed AgainSteven Y C Tong, Joshua S Davis
Pathology|October 31, 2025
Assessing yield and impact of 5-day versus 10-day incubation time in suspected prosthetic joint infection: a prospective laboratory studyVictoria Jordan, Joshua S Davis, Syeda Naqvi
Internal Medicine Journal|August 8, 2017
Knowledge of proprietary and generic drug names among hospital prescribers: time to mandate generic prescribing?Joshua S Davis, Thomas Barrett, Lisa Harris
Antibiotics (Basel, Switzerland)|October 27, 2023
Design Characteristics and Recruitment Rates for Randomized Trials of Peri-Prosthetic Joint Infection Management: A Systematic ReviewLaurens Manning, Bethwyn Allen, Joshua S Davis
Pageof 21

Showing results (1-10 of 210) with videos related to

Sort By:
Pageof 21
Trials|September 21, 2022
Creating concise and readable patient information sheets for interventional studies in Australia: are we there yet?Tanya Symons, Joshua S Davis
Australian and New Zealand Journal of Public Health|July 24, 2010
Acute hospital admission for sepsis: an important but under-utilised opportunity for smoking cessation interventionsMark McMillan, Joshua S Davis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Rhabdomyolysis associated with dengue virus infectionJoshua S Davis, Peter Bourke
Critical Care Medicine|December 15, 2010
Is plasma arginine concentration decreased in patients with sepsis? A systematic review and meta-analysisJoshua S Davis, Nicholas M Anstey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2019
Combination Therapy for MRSA Bacteremia: To ß or Not to ß?Thomas L Holland, Joshua S Davis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2020
Measuring the MeaningfulJohn F McNamara, Joshua S Davis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 16, 2020
Combination Therapy for Staphylococcus aureus Bacteremia: Hopes Dashed AgainSteven Y C Tong, Joshua S Davis
Pathology|October 31, 2025
Assessing yield and impact of 5-day versus 10-day incubation time in suspected prosthetic joint infection: a prospective laboratory studyVictoria Jordan, Joshua S Davis, Syeda Naqvi
Internal Medicine Journal|August 8, 2017
Knowledge of proprietary and generic drug names among hospital prescribers: time to mandate generic prescribing?Joshua S Davis, Thomas Barrett, Lisa Harris
Antibiotics (Basel, Switzerland)|October 27, 2023
Design Characteristics and Recruitment Rates for Randomized Trials of Peri-Prosthetic Joint Infection Management: A Systematic ReviewLaurens Manning, Bethwyn Allen, Joshua S Davis
Pageof 21